DK0831807T3 - Anvendelse af Brefeldin A og derivater deraf til fremstilling af lægemidler til behandling af hyperplasia og beslægtede lidelser - Google Patents

Anvendelse af Brefeldin A og derivater deraf til fremstilling af lægemidler til behandling af hyperplasia og beslægtede lidelser

Info

Publication number
DK0831807T3
DK0831807T3 DK96918159T DK96918159T DK0831807T3 DK 0831807 T3 DK0831807 T3 DK 0831807T3 DK 96918159 T DK96918159 T DK 96918159T DK 96918159 T DK96918159 T DK 96918159T DK 0831807 T3 DK0831807 T3 DK 0831807T3
Authority
DK
Denmark
Prior art keywords
brefeldin
derivatives
hyperplasia
intimal hyperplasia
methods
Prior art date
Application number
DK96918159T
Other languages
English (en)
Inventor
Charles E Hart
Connell Oliver J Mc
Theresa Martinez
Robert R West
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK0831807T3 publication Critical patent/DK0831807T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96918159T 1995-06-07 1996-06-04 Anvendelse af Brefeldin A og derivater deraf til fremstilling af lægemidler til behandling af hyperplasia og beslægtede lidelser DK0831807T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/483,216 US5618837A (en) 1995-06-07 1995-06-07 PDGF antagonists III

Publications (1)

Publication Number Publication Date
DK0831807T3 true DK0831807T3 (da) 2006-05-08

Family

ID=23919165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918159T DK0831807T3 (da) 1995-06-07 1996-06-04 Anvendelse af Brefeldin A og derivater deraf til fremstilling af lægemidler til behandling af hyperplasia og beslægtede lidelser

Country Status (9)

Country Link
US (1) US5618837A (da)
EP (1) EP0831807B1 (da)
JP (1) JP3190684B2 (da)
AT (1) ATE313324T1 (da)
AU (1) AU6048396A (da)
DE (1) DE69635614T2 (da)
DK (1) DK0831807T3 (da)
ES (1) ES2253750T3 (da)
WO (1) WO1996040112A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9807980A (pt) * 1997-02-05 2000-03-28 Allelix Pharm Eco L P Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva
WO1999031084A1 (en) 1997-12-18 1999-06-24 Purdue Research Foundation Brefeldin a derivatives
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
MXPA03002871A (es) 2000-09-29 2004-12-06 Johnson & Johnson Dispositivos medicos recubiertos.
US6696483B2 (en) 2000-10-03 2004-02-24 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
KR101501870B1 (ko) 2003-08-27 2015-03-12 옵쏘테크 코포레이션 안구의 혈관신생성 장애를 치료하기 위한 조합 치료법
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099363A1 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US8465912B2 (en) 2009-02-27 2013-06-18 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2012149014A1 (en) 2011-04-25 2012-11-01 OSI Pharmaceuticals, LLC Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
KR200490553Y1 (ko) * 2016-08-11 2019-11-28 왕 중 김 일회용 앞치마

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
CA2094858C (en) * 1992-04-28 2004-06-15 Robert D. Mitchell Method of treating hyperproliferative vascular disease
WO1995021614A1 (en) * 1994-02-09 1995-08-17 Ariad Pharmaceuticals, Inc. New protein trafficking inhibitors

Also Published As

Publication number Publication date
JP3190684B2 (ja) 2001-07-23
EP0831807B1 (en) 2005-12-21
US5618837A (en) 1997-04-08
DE69635614D1 (de) 2006-01-26
EP0831807A1 (en) 1998-04-01
ATE313324T1 (de) 2006-01-15
DE69635614T2 (de) 2006-07-27
WO1996040112A1 (en) 1996-12-19
ES2253750T3 (es) 2006-06-01
AU6048396A (en) 1996-12-30
JP2000513703A (ja) 2000-10-17

Similar Documents

Publication Publication Date Title
DK0835115T3 (da) 4-(2-(N-2-carboxamidoindo)aminoethyl)-benzensulfonamider eller -sulfonylurinstoffer som PDGF-antagonister
DK0801572T3 (da) Sammensætning til inhibering af intimal hyperplasi ved anvendelse af PDGF-antagonister og heparin
DK0831807T3 (da) Anvendelse af Brefeldin A og derivater deraf til fremstilling af lægemidler til behandling af hyperplasia og beslægtede lidelser
TR199701567T1 (xx) Rapamisin t�revleri.
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
PT91863A (pt) Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao
ATE424893T1 (de) Behandlung und vorbeugung von insulin- produzierende zelltransplantatabstossung
ATE293973T1 (de) Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria
SE9603725D0 (sv) New teatment
WO2003033009A3 (en) Novel drug targets for arthritis
DK0680323T3 (da) Synergistisk kombination med antagonistvirkning ved NK1- og Nk2-receptorer.
DE69413009D1 (de) Verwendung von antikörpern gegen pdgf-rezeptoren zur inhibierung von hyperplasie der intima
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
NO984572L (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
ATE286122T1 (de) Protein c derivate
ATE147936T1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
CY1106540T1 (el) Ετεροκυλικα υποκατεστημενες στη θεση 3 πιπεριδινο-2,6-διονες
Reddy et al. Dabigatran etexilate-A novel oral anticoagulant for bleeding complications
UA27780C2 (uk) Діюча речовина лікарського засобу для лікування або профілактики артеріосклерозу та/або асоційованих з ним серцево-судинних захворювань, спосіб лікування або профілактики артеріосклерозу у ссавців та лікарський засіб, що в ньому використовується
ITMI951252A0 (it) Bicarbonati di derivati della 2,6-dimetilanilina loro uso in terapia e composizioni farmaceutiche che li comprendono
DK0872238T3 (da) Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin
UA34143A (uk) Спосіб ендартеректомії із стегнових і здухвинних артерій та дезоблітератор